US Medical Head, Dyslipidemia
AstraZeneca - US - Wilmington - DE
Posted Nov 10, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified checked Nov 20, 2026
- Salary
- Not verified
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Market context
- U.S. role benchmark (BLS OEWS)
- $81,444 U.S. median for this role
- Projected growth (BLS Employment Projections)
- +6.9% - Faster than average
Matched to SOC 29-1141 - Healthcare aggregate by role bucket.
Source:U.S. Bureau of Labor Statistics, OEWS, May 2024andEmployment Projections, 2024-2034.
Role
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
US Medical Head, Dyslipidemia US - Wilmington - DE At AstraZeneca we work together across global boundaries to make an impact and find answers to challenges. We do this with the utmost integrity even in the most difficult situations because we are committed to doing the right thing. We continuously forge partnerships that help pursue world-class medicines in new ways, combining our people's exceptional skills with those of people from all over the globe. AstraZeneca holds an outstanding position in CVRM disease, with a range of medicines both on the market and in development, with an industry leading pipeline. The US Head of Medical - Dyslipidemia is a leadership position that reports directly to the VP Medical Cardiovascular Renal Metabolism (CVRM), within the BioPharmaceuticals Business Unit's US Medical CVRM franchise. The successful candidate will lead a team to develop product and disease area strategies and drive product launches for our novel oral PCSK9 inhibitor across the life-cycle. What you'll do: Build and lead the dyslipidemia medical team, with accountability for the development and execution of disease area and brand strategies and plans Accountable for disease area and brand budget and resource requirements Partner effectively with the Commercial Lead, role-modeling effective teamwork across the enterprise Effectively act as the US point of contact for the Global Product Team (GPT) Provide the US viewpoint into life-cycle management/phase IV strategy and study design Develop and maintain positive relationships with key external and internal customers Anticipate future trends and needs in the marketplace Coach,
Read the full description at astrazeneca.wd3.myworkdayjobs.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Medical Director, Dyslipidemia
AstraZeneca - US - Wilmington - DE
Dist Suppt Pharmacist PT #5068
CVS Health Corporation - NV - Las Vegas
Asset Lead Medical Director - Obesity and Related Conditions
Amgen - United States - Remote
Vice President, US Medical Neurology
Genentech, Inc. - South San Francisco, California, United States of America